1. Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication
    , 2018, Viruses CrossRef
  2. Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
    Wishrawana S. Ratnayake et al, 2018, Cell Adhesion & Migration CrossRef
  3. A Novel Atypical PKC-Iota Inhibitor, Echinochrome A, Enhances Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells
    Hyoung Kim et al, 2018, Marine Drugs CrossRef
  4. FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation
    WISHRAWANA RATNAYAKE et al, 2018, wasj CrossRef
  5. null
    Wishrawana S. Ratnayake et al, 2019 CrossRef
  6. aPKC in neuronal differentiation, maturation and function
    Sophie M. Hapak et al, 2019, Neuronal Signal. CrossRef
  7. Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway.
    Raja Reddy BommaReddy et al, 2020, Onco Targets Ther CrossRef
  8. Targeting Rho GTPase Signaling Networks in Cancer
    Natasha S. Clayton et al, 2020, Front. Cell Dev. Biol. CrossRef
  9. Simultaneous inhibition of atypical protein kinase‑C and mTOR impedes bladder cancer cell progression
    Rekha Patel et al, 2020, Int J Oncol CrossRef
  10. High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients
    Yuka Nozaki et al, 2020, PLoS ONE CrossRef
  11. Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
    Wishrawana S. Ratnayake et al, 2021, Cell Adhesion & Migration CrossRef
  12. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells
    Jia-Xi Duan et al, 2021, International Immunopharmacology CrossRef
  13. Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
    Takahito Kawano et al, 2021, Pharmaceutics CrossRef
  14. Juvenile hormone promotes paracellular transport of yolk proteins via remodeling zonula adherens at tricellular junctions in the follicular epithelium
    Hongyuan Zheng et al, 2022, PLoS Genet CrossRef
  15. Intermediate filaments: Integration of cell mechanical properties during migration
    Elvira Infante et al, 2022, Front. Cell Dev. Biol. CrossRef
  16. Insulin stimulates atypical protein kinase C‐mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6‐Rac1 signaling
    Dennis Dik‐Long Chau et al, 2022, The FASEB Journal CrossRef
  17. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
    Takahito Kawano et al, 2022, Cancers CrossRef
  18. Regulation of Inflammation-Mediated Endothelial to Mesenchymal Transition with Echinochrome a for Improving Myocardial Dysfunction
    Byeong-Wook Song et al, 2022, Marine Drugs CrossRef
  19. 14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression
    S. Breedy et al, 2023, Front. Oncol. CrossRef
  20. Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma
    Khandker Mohammad Khalid et al, 2024, Front. Oncol. CrossRef